May 6, 2020 / 10:49 AM / 20 days ago

BRIEF-Jounce Therapeutics Reports Q1 Loss Per Share Of $0.78

May 6 (Reuters) - Jounce Therapeutics Inc:

* JOUNCE THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $0.78

* Q1 EARNINGS PER SHARE ESTIMATE $-0.57 — REFINITIV IBES DATA

* JOUNCE THERAPEUTICS - UPDATING GUIDANCE ON EMERGE AND SELECT PHASE 2 TRIALS DUE TO COVID-19

* JOUNCE THERAPEUTICS -CURRENTLY EXPECTS DELAY OF ABOUT 2 TO 3 MONTHS TO EMERGE INTERIM ANALYSIS & INITIATION OF SELECT CLINICAL TRIAL DUE TO COVID-19

* DID NOT RECOGNIZE ANY LICENSE AND COLLABORATION REVENUE IN Q1 OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below